Description
CJC-1295 is a peptide hormone that consists of 30 amino acids. In the human body, it functions as an analog of somatoliberin (a natural stimulator of growth hormone secretion). It works on the nucleus of the anterior pituitary gland and stimulates the secretion of growth hormone. The substance binds to GHRH receptors, which belong to the group of G-protein-coupled receptors. The CJC-1295 version of DAC (Drug Affinity Complex) binds to plasma proteins (albumin), which leads to a significant increase in the duration of action, due to the addition of lysine bound to the non-peptide DAC molecule (the version without DAC lasts 30 min).
GHRH drugs are not usually used alone, but are most often used in combination with a GHRP class peptide such as GHRP-2, GHRP-6, hexarelin or ipamorelin. Examples of use are 100 mcg CJC1295 taken concomitantly with 100 mcg GHRP-6 or ipamorelin. This combination is synergistic. GHRP stimulates the GH release impulse and GHRP amplifies it. Dosage when combined with GHRP should be approximately 100 micrograms. The dosage of CJC 1295 DAC should be 1000 mcg (1 mg) twice a week.
